Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Campos A, Campos EJ, do Carmo A, Patricio M, Castro de Sousa JP, Ambrosio AF, Silva RC (2018) Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. https://doi.org/10.1007/s00417-018-4072-z Published online: July 23, 2018

  2. 2.

    Călugăru D, Călugăru M (2018) Early response tointravitreal dexamethasone implant therapy in diabetic macular edema may predict visual outcome. Am J Ophthalmol 186:164–165

    Article  PubMed  Google Scholar 

  3. 3.

    Călugăru D, Călugăru M (2017) Real-world outcomes of ranibizumab treatment for diabetic macular edema in a United Kingdom National Health Service settting. Am J Ophthalmol 174:175–176

    Article  PubMed  Google Scholar 

  4. 4.

    Călugăru D, Călugăru M (2017) Outcomes with as-needed aflibercept and macular laser following the phase lll Vista DME trial: endurance 12-month extension study. Am J Ophthalmol 177:235–236

    Article  PubMed  Google Scholar 

  5. 5.

    Călugăru D, Călugăru M (2018) Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment. Am J Ophthalmol 256:1035–1037

    Google Scholar 

  6. 6.

    Călugăru D, Călugăru M (2018) Aflibercept in diabetic macular edema refractory to previous bevacizumab; outcomes and predictors of success. Graefes Arch Clin Exp Ophtalmol 256:1353–1354

    Article  Google Scholar 

  7. 7.

    Gover S, Murthy RK, Brar VS, Chalam KV (2009) Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (Spectralis). Am J Ophthalmol 148:266–271

    Article  Google Scholar 

  8. 8.

    Călugăru D, Călugăru M (2016) Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular edema. Am J Ophthalmol 168:290–291

    Article  PubMed  Google Scholar 

  9. 9.

    Zhang C, Tatham AJ, Medeiros FA, Zangwill LM, Yang Z, Weinreb RN (2014) Assessment of choroidal thickness in healthy and glaucomatous eyes using swept source optical coherence tomography. PLoS One 9(10):e109683

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Yiu G, Manjunath V, Chiu SJ, Farsiu S, Mahmoud TH (2014) Effect of anti-vascular endothelial growth factor therapy on choroidal thickness in diabetic macular edema. Am J Ophthalmol 158:745–751

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Contributions

Both authors (D.C and M.C) were involved in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review, or approval of the manuscript.

Corresponding author

Correspondence to Mihai Călugăru.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Disclaimer

The authors have full control over the primary data and they agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data if requested.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Călugăru, D., Călugăru, M. Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 257, 241–242 (2019). https://doi.org/10.1007/s00417-018-4126-2

Download citation